Selected article for: "clinical trial and pharmaceutical intervention"

Author: Forman, Henry Jay; Zhang, Hongqiao
Title: Targeting oxidative stress in disease: promise and limitations of antioxidant therapy
  • Cord-id: 6ewgcv0b
  • Document date: 2021_6_30
  • ID: 6ewgcv0b
    Snippet: Oxidative stress is a component of many diseases, including atherosclerosis, chronic obstructive pulmonary disease, Alzheimer disease and cancer. Although numerous small molecules evaluated as antioxidants have exhibited therapeutic potential in preclinical studies, clinical trial results have been disappointing. A greater understanding of the mechanisms through which antioxidants act and where and when they are effective may provide a rational approach that leads to greater pharmacological succ
    Document: Oxidative stress is a component of many diseases, including atherosclerosis, chronic obstructive pulmonary disease, Alzheimer disease and cancer. Although numerous small molecules evaluated as antioxidants have exhibited therapeutic potential in preclinical studies, clinical trial results have been disappointing. A greater understanding of the mechanisms through which antioxidants act and where and when they are effective may provide a rational approach that leads to greater pharmacological success. Here, we review the relationships between oxidative stress, redox signalling and disease, the mechanisms through which oxidative stress can contribute to pathology, how antioxidant defences work, what limits their effectiveness and how antioxidant defences can be increased through physiological signalling, dietary components and potential pharmaceutical intervention.

    Search related documents:
    Co phrase search for related documents
    • Try single phrases listed below for: 1